欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/3543/002
药品名称	Imatinib Liconsa Pharma
活性成分	imatinib mesilate 358.41 mg
剂型	Film-coated tablet
上市许可持有人	Laboratorios Liconsa S.A. Gran Via Carlos III, 98, 7th Floor 08028 Barcelona Spain
参考成员国 - 产品名称	Germany (DE) Imatinib Liconsa Pharma 300 mg Filmtabletten
互认成员国 - 产品名称	Poland (PL)
许可日期	2014/03/13
最近更新日期	2018/04/18
药物ATC编码	L01XE01 imatinib
申请类型	TypeLevel1：Abridged TypeLevel2：Additional Strength/Form TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final Product Information \| common-final-pl-3543(001)-V002GDate of last change:2017/09/25 Final Product Information \| common-final-spc-3543(002)-V002GDate of last change:2017/09/25 Final Product Information \| common-final-pl-3543(002)-V002GDate of last change:2017/09/25 Final Product Information \| common-final-pl-3543(003)-V002GDate of last change:2017/09/25 Final Product Information \| common-final-spc-3543(001)-V002GDate of last change:2017/09/25 Final Product Information \| common-final-spc-3543(003)-V002GDate of last change:2017/09/25
市场状态	Positive